2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...
Transcript of 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...
![Page 1: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/1.jpg)
2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 , 2 0 2 0
![Page 2: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/2.jpg)
Not for promotional use 2
![Page 3: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/3.jpg)
Not for promotional use 3
![Page 4: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/4.jpg)
Not for promotional use 4
•
•
•
•
•
•
•
•
•
•
•
•
![Page 5: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/5.jpg)
Not for promotional use 5
•
•
•
•
•
•
•
•
•
•
•
•
•
•
![Page 6: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/6.jpg)
Not for promotional use 6
•
•
•
•
•
•
•
•
![Page 7: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/7.jpg)
Not for promotional use 7
![Page 8: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/8.jpg)
Not for promotional use 8
![Page 9: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/9.jpg)
Not for promotional use 9
![Page 10: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/10.jpg)
Not for promotional use 10
o
o
o o
o
o
![Page 11: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/11.jpg)
Not for promotional use 11
![Page 12: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/12.jpg)
Not for promotional use 12
![Page 13: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/13.jpg)
Not for promotional use 13
![Page 14: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/14.jpg)
Not for promotional use 14
![Page 15: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/15.jpg)
Not for promotional use 15
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
▪
![Page 16: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/16.jpg)
AUTOMATED INSULIN DELIVERY SYS Diabetes
BASAL INSULIN-FCDiabetes
OXYNTOMODULINDiabetes
AUR A KINASE INHIBITOR Cancer
MIRIKIZUMABCrohn’s Disease
BARICITINIB Systemic Lupus Erythematosus
MEVIDALEN (D1 PAM)Dementia
ZAGOTENEMAB (TAU MAB) Alzheimer’s
TIRZEPATIDEDiabetes
DONANEMAB (N3PG Ab MAB) Alzheimer’s
BARICITINIBAtopic Dermatitis
EMPAGLIFLOZIN*Heart Failure pEF
TANEZUMAB*Cancer Pain
ABEMACICLIBAdjuvant Breast Cancer
MIRIKIZUMABPsoriasis
TANEZUMAB*Osteoarthritis Pain
SOLANEZUMABPreclinical AD
MIRIKIZUMABUlcerative Colitis
BARICITINIBAlopecia Areata
NME
NILEX
*
MOVEMENT SINCEJuly 28, 2020
ACHIEVED MILESTONE
REMOVALCommercial
Collaboration
OLARATUMABPancreatic Cancer
BTLA MAB AGONISTImmunology
ABEMACICLIBProstate Cancer
PD-1 MAB AGONISTImmunology
CD200R MAB AGONISTImmunology
PACAP38 MABPain
BTK INHIBITOR (LOXO-305) Cancer
EMPAGLIFLOZIN*Chronic Kidney Disease
O-GLCNACASE INHAlzheimer’s
GGG TRI-AGONISTDiabetes
CDK7 INHIBITORCancer
CONNECTED CARE PREFILLED INSULIN PEN Diabetes
GLP-1R NPADiabetes
TRPA1 ANTAGONIST Pain
SSTR4 AGONISTPain
D1 PAM IIDementia
ANGPTL3/8 MABCVD
SERDCancer
TIRZEPATIDEObesity
LEBRIKIZUMABAtopic Dermatitis
SELPERCATINIB1L Med Thyroid Cancer
SELPERCATINIB1L NSCLC
TIRZEPATIDENASH
GIP/GLP COAGONIST PEPTIDE Diabetes
N3PG Ab MABAlzheimer’s
BARICITINIB^COVID-19
BAMLANIVIMAB^(LY-CoV555) COVID-19
ETESEVIMAB+
(LY-CoV016) COVID-19
TIRZEPATIDECV Outcomes
EPIREG/TGFaMABChronic Pain
NRG4 AGONISTHeart Failure
EMPAGLIFLOZIN*Heart Failure rEF
KHK INHIBITORNASH / Diabetes
IL-2 CONJUGATEImmunology
CXCR1/2L MABImmunology
ANGIOPOIETIN 2MAB COVID-19
LP(a) INHIBITORCVD
DULAGLUTIDE3.0 / 4.5 mg
CD73 INHIBITORCancer
TAU MORPHOMERAlzheimer’s
GDF 15 AGONISTDiabetes
^ Under Regulatory Review for
Emergency Use Authorization
+ In combination with bamlanivimab, potentially
registrational study
IDH1 INHIBITOR Cancer
Not for promotional use
![Page 17: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/17.jpg)
Not for promotional use
17
✓
✓
✓
✓ ✓
✓ ✓
✓ ✓
✓
✓
✓
✓
✓-
✓-
✓ ✓✓
✓
New since last update
✓
✓
✓
✓
✓ ✓
✓
✓
✓
✓ ✓
✓
✓
✓
✓
✓
✓
✓
✓ `
✓
✓
✓
![Page 18: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/18.jpg)
Not for promotional use 18
▪
▪
▪
▪
▪
•
•
•
•
![Page 19: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/19.jpg)
![Page 20: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/20.jpg)
Not for promotional use 20
![Page 21: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/21.jpg)
Not for promotional use 21
![Page 22: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/22.jpg)
Not for promotional use 22
![Page 23: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/23.jpg)
Not for promotional use 23
![Page 24: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/24.jpg)
Not for promotional use 24
![Page 25: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/25.jpg)
Not for promotional use 25
•
•
•
•
![Page 26: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/26.jpg)
Not for promotional use 26
•
•
•
•
•
•
•
•
•
![Page 27: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/27.jpg)
Not for promotional use 27
![Page 28: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/28.jpg)
Not for promotional use 28
![Page 29: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/29.jpg)
Not for promotional use 29
![Page 30: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/30.jpg)
Not for promotional use 30
![Page 31: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/31.jpg)
Not for promotional use 31
![Page 32: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/32.jpg)
Not for promotional use 32
![Page 33: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/33.jpg)
Not for promotional use 33
![Page 34: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/34.jpg)
Not for promotional use 34
•
•
•
![Page 35: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/35.jpg)
Not for promotional use 35
![Page 36: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/36.jpg)
Not for promotional use 36
•
•
•
![Page 37: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/37.jpg)
Not for promotional use 37
![Page 38: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/38.jpg)
Not for promotional use 38
![Page 39: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/39.jpg)
Not for promotional use 39
![Page 40: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/40.jpg)
Not for promotional use 40
<≥
![Page 41: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/41.jpg)
Not for promotional use 41
>
>
>
![Page 42: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/42.jpg)
Not for promotional use 42
![Page 43: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/43.jpg)
Not for promotional use 43
![Page 44: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/44.jpg)
Not for promotional use 44
<
<
![Page 45: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/45.jpg)
Not for promotional use 45
![Page 46: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/46.jpg)
Not for promotional use 46
![Page 47: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/47.jpg)
Not for promotional use 47
![Page 48: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/48.jpg)
Not for promotional use 48
![Page 49: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/49.jpg)
Not for promotional use 49
![Page 50: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/50.jpg)
Not for promotional use 50
![Page 51: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/51.jpg)
Not for promotional use 51
![Page 52: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/52.jpg)
Not for promotional use 52
![Page 53: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/53.jpg)
Not for promotional use 53
![Page 54: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/54.jpg)
Not for promotional use 54
>
![Page 55: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/55.jpg)
Not for promotional use 55
![Page 56: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/56.jpg)
Not for promotional use 56
β
β
![Page 57: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/57.jpg)
Not for promotional use 57
β
![Page 58: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/58.jpg)
Not for promotional use 58
![Page 59: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/59.jpg)
Not for promotional use 59
![Page 60: 2 0 2 0 B U S I N E S S R E S U L T S O C T O B E R 2 7 ...](https://reader031.fdocuments.us/reader031/viewer/2022012015/615a58d0bf8b354bd45588b2/html5/thumbnails/60.jpg)